BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹438 Cr | ₹404 Cr | ₹385 Cr | ₹393 Cr | ₹464 Cr |
What is the latest Sundry Debtors ratio of BLISS GVS PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹438 Cr |
| Mar2024 | ₹404 Cr |
| Mar2023 | ₹385 Cr |
| Mar2022 | ₹393 Cr |
| Mar2021 | ₹464 Cr |
How is Sundry Debtors of BLISS GVS PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹438 Cr | 8.41 | |
| Mar2024 | ₹404 Cr | 4.98 | |
| Mar2023 | ₹385 Cr | -1.93 | |
| Mar2022 | ₹393 Cr | -15.32 | |
| Mar2021 | ₹464 Cr | - | |
Compare Sundry Debtors of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,832.8 Cr | -0.5% | 19.7% | 113.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,830.0 Cr | 5.9% | -0.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,484.0 Cr | 2.5% | 8.7% | 3.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,166.0 Cr | 2% | -1.6% | 25.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,018.0 Cr | -0.2% | 2.2% | 12.8% | Stock Analytics | |
| CIPLA | ₹106,357.0 Cr | 0.8% | 5.9% | -15.7% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -0.5% |
19.7% |
113.2% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses